Welcome to the Clot Chronicles, a video series for healthcare professionals covering all aspects of thromboembolic disease and related conditions. Tune in biweekly for 5-minute updates on new research and clinical best practices.

Have an idea for the next episode? Email Aviva, NATF’s Director of Content Development, at aschwartz@natfonline.org.

Clot Chronicles: The MARINER Trial

Dr. Sam Goldhaber discusses the results of the MARINER trial. As an added bonus, Dr. James Welker provides his commentary.…

Clot Chronicles: 2018 NATF Summit

Dr. Sam Goldhaber discusses the upcoming 2018 NATF Summit and the importance of understanding the connection between diabetes, metabolic syndrome,…

Clot Chronicles: Andexanet

Dr. Sam Goldhaber discusses the newest development in anticoagulant medications, a new reversal agent called andexanet. Hello, this is Dr.…